ABCSG 32 Summary
Multicentre, randomized phase-II-study of neoadjuvant trastuzumab plus docetaxel with and without bevacizumab and trastuzumab plus non-pegylated liposome-encapsulated doxorubicin (NPLD) with and without bevacizumab
|Coordinating investigator:||Steger, Günther; Vienna|
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.